S&P 500   2,954.22 (-0.82%)
DOW   25,409.36 (-1.39%)
QQQ   205.80 (+0.08%)
AAPL   273.36 (-0.06%)
MSFT   162.01 (+2.42%)
AMZN   1,883.75 (-0.03%)
NVDA   270.07 (+6.92%)
TSLA   667.99 (-1.62%)
AMD   45.48 (+3.34%)
T   35.22 (-1.43%)
F   6.96 (-0.14%)
BAC   28.50 (-2.16%)
S&P 500   2,954.22 (-0.82%)
DOW   25,409.36 (-1.39%)
QQQ   205.80 (+0.08%)
AAPL   273.36 (-0.06%)
MSFT   162.01 (+2.42%)
AMZN   1,883.75 (-0.03%)
NVDA   270.07 (+6.92%)
TSLA   667.99 (-1.62%)
AMD   45.48 (+3.34%)
T   35.22 (-1.43%)
F   6.96 (-0.14%)
BAC   28.50 (-2.16%)
S&P 500   2,954.22 (-0.82%)
DOW   25,409.36 (-1.39%)
QQQ   205.80 (+0.08%)
AAPL   273.36 (-0.06%)
MSFT   162.01 (+2.42%)
AMZN   1,883.75 (-0.03%)
NVDA   270.07 (+6.92%)
TSLA   667.99 (-1.62%)
AMD   45.48 (+3.34%)
T   35.22 (-1.43%)
F   6.96 (-0.14%)
BAC   28.50 (-2.16%)
S&P 500   2,954.22 (-0.82%)
DOW   25,409.36 (-1.39%)
QQQ   205.80 (+0.08%)
AAPL   273.36 (-0.06%)
MSFT   162.01 (+2.42%)
AMZN   1,883.75 (-0.03%)
NVDA   270.07 (+6.92%)
TSLA   667.99 (-1.62%)
AMD   45.48 (+3.34%)
T   35.22 (-1.43%)
F   6.96 (-0.14%)
BAC   28.50 (-2.16%)
Log in

Dechra Pharmaceuticals Price Target & Analyst Ratings (LON:DPH)

GBX 2,646
-24.00 (-0.90 %)
(As of 02/28/2020 04:00 PM ET)
Today's Range
2,524
Now: GBX 2,646
2,660
50-Day Range
2,670
MA: GBX 2,883.80
3,068
52-Week Range
2,336
Now: GBX 2,646
3,090
Volume634,859 shs
Average Volume282,452 shs
Market Capitalization£2.72 billion
P/E Ratio87.91
Dividend Yield1.11%
BetaN/A

Analyst Ratings

Dechra Pharmaceuticals (LON:DPH) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
4 Wall Street analysts have issued ratings and price targets for Dechra Pharmaceuticals in the last 12 months. Their average twelve-month price target is GBX 2,920The high price target for DPH is GBX 3,300 and the low price target for DPH is GBX 2,500. There are currently 3 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldBuyBuy
Consensus Rating Score: 2.252.252.752.60
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: GBX 2,920GBX 2,895GBX 2,876.25GBX 2,651.25

Dechra Pharmaceuticals (LON:DPH) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Dechra Pharmaceuticals (LON:DPH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
2/25/2020JPMorgan Chase & Co.Boost Price TargetOverweightGBX 3,200 ➝ GBX 3,300
1/21/2020Jefferies Financial GroupDowngradeHoldGBX 3,090 ➝ GBX 2,930
12/2/2019HSBCBoost Price TargetHoldGBX 2,915 ➝ GBX 2,950
9/2/2019Royal Bank of CanadaBoost Price TargetSector PerformGBX 2,100 ➝ GBX 2,500
9/3/2018Numis SecuritiesDowngradeHold
(Data available from 2/28/2018 forward)
This page was last updated on 2/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel